Design Therapeutics Inc. (DSGN)
NASDAQ: DSGN
· Real-Time Price · USD
5.35
0.19 (3.68%)
At close: Aug 15, 2025, 3:59 PM
5.33
-0.37%
After-hours: Aug 15, 2025, 04:04 PM EDT
Design Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 588K | n/a | n/a | n/a | 838K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 152K | 159K | 149K | 153K | 151K | 143K | 138K | 137K | 143K | 139K | 135K | 122K | 113K | 96K | 82K | 31K | 12K | 4K |
Gross Profit | -152K | -159K | 294K | -153K | -151K | -143K | -138K | -137K | -143K | -139K | -135K | -122K | -113K | -96K | -82K | -31K | -12K | -4K |
Operating Income | -21.57M | -20.42M | -16.69M | -16.25M | -15.04M | -14.4M | -15.12M | -18.82M | -22.6M | -21.65M | -19.39M | -19.19M | -15.64M | -13.37M | -11.13M | -11.34M | -7.69M | -5.68M |
Interest Income | 2.49M | 2.7M | 3.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -19.08M | -17.71M | -13.65M | -13.04M | -11.79M | -11.11M | -11.84M | -15.79M | -19.94M | -19.29M | -17.34M | -17.7M | -15M | -13.27M | -11.06M | -11.32M | -7.64M | -5.51M |
Net Income | -19.08M | -17.71M | -13.65M | -13.04M | -11.79M | -11.11M | -11.84M | -15.79M | -19.94M | -16.94M | -15.16M | -16.22M | -14.36M | -13.16M | -11.06M | -11.32M | -7.64M | -5.51M |
Selling & General & Admin | 5.83M | 5.04M | 4.54M | 4.37M | 4.53M | 4.6M | 4.11M | 5.57M | 5.53M | 5.92M | 5.14M | 4.89M | 4.34M | 4.61M | 3.79M | 2.8M | 2.66M | 1.8M |
Research & Development | 15.74M | 15.38M | 12.16M | 11.88M | 10.37M | 9.66M | 10.87M | 13.26M | 17.06M | 15.73M | 14.26M | 14.3M | 11.29M | 8.76M | 7.34M | 8.54M | 5.03M | 3.88M |
Other Expenses | n/a | n/a | -149K | n/a | n/a | n/a | n/a | -137K | n/a | n/a | n/a | n/a | n/a | 105K | 62K | 19K | 51K | n/a |
Operating Expenses | 21.57M | 20.42M | 16.55M | 16.25M | 14.89M | 14.26M | 14.98M | 18.68M | 22.6M | 21.65M | 19.39M | 19.19M | 15.64M | 13.37M | 11.13M | 11.34M | 7.69M | 5.68M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 129K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 76K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 21.57M | 20.42M | 16.69M | 16.25M | 15.04M | 14.4M | 15.12M | 18.82M | 22.6M | 21.65M | 19.39M | 19.19M | 15.64M | 13.37M | 11.13M | 11.34M | 7.69M | 5.68M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.91K | -2.36M | -2.18M | -1.49M | -640K | -105K | -62K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 56.86M | 56.76M | 56.68M | 56.62M | 56.56M | 56.49M | 56.15M | 55.99M | 55.95M | 55.91M | 55.86M | 55.78M | 55.67M | 55.51M | 55.36M | 55.16M | 55.08M | 17.63M |
Shares Outstanding (Diluted) | 56.86M | 56.76M | 56.68M | 56.62M | 56.56M | 56.49M | 56.15M | 55.99M | 55.95M | 55.91M | 55.86M | 55.78M | 55.67M | 55.51M | 55.36M | 55.16M | 55.08M | 17.63M |
EPS (Basic) | -0.34 | -0.31 | -0.24 | -0.23 | -0.21 | -0.2 | -0.21 | -0.28 | -0.36 | -0.3 | -0.27 | -0.29 | -0.26 | -0.24 | -0.2 | -0.21 | -0.14 | -0.31 |
EPS (Diluted) | -0.34 | -0.31 | -0.24 | -0.23 | -0.21 | -0.2 | -0.21 | -0.28 | -0.36 | -0.3 | -0.27 | -0.29 | -0.26 | -0.24 | -0.2 | -0.21 | -0.14 | -0.31 |
EBITDA | -21.57M | -20.26M | -16.55M | -16.09M | -14.89M | -14.26M | -14.98M | -18.68M | -22.46M | -21.52M | -19.27M | -19.08M | -15.55M | -13.29M | -11.04M | -11.31M | -7.67M | -5.68M |
EBIT | -19.08M | -20.42M | -16.69M | -16.25M | -15.04M | -14.4M | -15.12M | -18.82M | -22.6M | -21.65M | -19.39M | -19.19M | -15.64M | -13.37M | -11.13M | -11.34M | -7.69M | -5.68M |
Depreciation & Amortization | 152K | 159K | 149K | 153K | 151K | 143K | 138K | 137K | 143K | 139K | 135K | 122K | 113K | 96K | 82K | 31K | 12K | 4K |